|
Autoexperimentation
|
H01.770.644.145.365.100 |
|
|
Buprenorphine
|
D04.615.723.795.150 |
|
|
Pulmonary Atelectasis
|
C08.381.730 |
|
|
Neurokinin A
|
D12.644.400.800.500 |
|
|
Intensive Care Units, Neonatal
|
N02.278.388.493.390.380 |
|
|
Intensive Care Units, Pediatric
|
N02.278.388.493.390 |
|
|
Facial Paralysis
|
C10.597.622.214 |
|
|
Manufactured Materials
|
J01.637 |
|
|
Bromodeoxyuridine
|
D13.570.230.430.196 |
|
|
Thyroid Nodule
|
D016606 |
[A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter (GOITER, NODULAR).
] |
|
Pulmonary Edema
|
C08.381.742 |
|
|
Eosinophilia-Myalgia Syndrome
|
D016603 |
[A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
] |
|
Aflatoxin B1
|
D016604 |
[A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1.
] |
|
Neoplasms, Second Primary
|
D016609 |
[Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.
] |
|
Furunculosis
|
C22.362.224 |
|
|
High Mobility Group Proteins
|
D12.776.660.235.400 |
|
|
Social Evolution
|
D000083645 |
[The process of cumulative change that arise over over successive generations in social interactions, especially between individuals of the same species,
] |
|
Pulmonary Embolism
|
C08.381.746 |
|
|
Aflatoxin M1
|
D016607 |
[A 4-hydroxylated metabolite of AFLATOXIN B1, one of the MYCOTOXINS from ASPERGILLUS tainted food. It is associated with LIVER damage and cancer resulting from its P450 activation to the epoxide which alkylates DNA. Toxicity depends on the balance of liver enzymes that activate it (CYTOCHROME P-450) and others that detoxify it (GLUTATHIONE S TRANSFERASE) (Pharmac Ther 50.443 1991). Primates & rat are sensitive while mouse and hamster are tolerant (Canc Res 29.236 1969).
] |
|
Talin
|
D016608 |
[A 235-kDa cytoplasmic protein that is also found in platelets. It has been localized to regions of cell-substrate adhesion. It binds to INTEGRINS; VINCULIN; and ACTINS and appears to participate in generating a transmembrane connection between the extracellular matrix and the cytoskeleton.
] |
